On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Genomed, Diagnosticos de Medicina Molecular SA's own share of each project, not the project's full budget.
- Horizon 2020€277k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- LysoModPartner
Genetic and Small Molecule Modifiers of Lysosomal Function
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€277ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Weizmann Institute of ScienceIsrael · 1 shared project
- The University of SussexUnited Kingdom · 1 shared project
- Fondazione Telethon EtsItaly · 1 shared project
- Instituto de Medicina Molecular Joao Lobo AntunesPortugal · 1 shared project
- Pontificia Universidad Catolica de ChileChile · 1 shared project
- LipotypeGermany · 1 shared project
- Universidad de Buenos AiresArgentina · 1 shared project
- Institutul de BiochimieRomania · 1 shared project
- The Children'S Hospital of Philadelphia Non Profit OrgUnited States · 1 shared project
- Chronos Biosystems SRLRomania · 1 shared project
- Intrabio LtdUnited Kingdom · 1 shared project
- Universidad del DesarrolloChile · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- hepatology
- medical genetics
- medicinal chemistry
- public health
- stem cells
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
